From efficacy to equity: Literature review of decision criteria for resource allocation and healthcare decisionmaking

[1]  J. Wale.  Faculty Opinions recommendation of Bridging health technology assessment (HTA) and efficient health care decision making with multicriteria decision analysis (MCDA): applying the EVIDEM framework to medicines appraisal. , 2012 .

[2]  D. Asch,et al.  Assessing value in health care programs. , 2012, JAMA.

[3]  A. Culyer,et al.  An Equity Framework for Health Technology Assessments , 2012, Medical decision making : an international journal of the Society for Medical Decision Making.

[4]  V. Diaby,et al.  PRM12 An Application of a Proposed Framework for Formulary Listing in Low-income Countries: Case of Côte d'Ivoire , 2011 .

[5]  B. Hofmann,et al.  Tackling ethical issues in health technology assessment: A proposed framework , 2011, International Journal of Technology Assessment in Health Care.

[6]  V. Diaby,et al.  A Proposed Framework for Formulary Listing in Low-Income Countries , 2011, Pharmaceutical Medicine.

[7]  R. Baltussen,et al.  Multi-criteria decision analysis to prioritize health interventions: Capitalizing on first experiences. , 2010, Health policy.

[8]  Uwe Siebert,et al.  EBM, HTA, and CER: clearing the confusion. , 2010, The Milbank quarterly.

[9]  C. Deal,et al.  Combining multicriteria decision analysis, ethics and health technology assessment: applying the EVIDEM decisionmaking framework to growth hormone for Turner syndrome patients , 2010, Cost effectiveness and resource allocation : C/E.

[10]  M. Koopmanschap,et al.  Dear policy maker: Have you made up your mind? A discrete choice experiment among policy makers and other health professionals , 2010, International Journal of Technology Assessment in Health Care.

[11]  Peggy A. Honoré,et al.  Decision science: a scientific approach to enhance public health budgeting. , 2010, Journal of public health management and practice : JPHMP.

[12]  J. Craig,et al.  Nephrologists' perspectives on the effect of guidelines on clinical practice: a semistructured interview study. , 2010, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[13]  G. Freed,et al.  Basis for immunization recommendations among countries of the World Health Organization European region , 2009, Human vaccines.

[14]  F. Dionne,et al.  Evaluation of the impact of program budgeting and marginal analysis in Vancouver Island Health Authority , 2009, Journal of health services research & policy.

[15]  Lydia Kapiriri,et al.  Setting priorities for health interventions in developing countries: a review of empirical studies , 2009, Tropical medicine & international health : TM & IH.

[16]  R. Lopert.  Evidence-based decision-making within Australia's pharmaceutical benefits scheme. , 2009, Issue brief.

[17]  David Hailey,et al.  A preliminary survey on the influence of rapid health technology assessments , 2009, International Journal of Technology Assessment in Health Care.

[18]  K. Chalkidou,et al.  Comparative effectiveness research and evidence-based health policy: experience from four countries. , 2009, The Milbank quarterly.

[19]  A. Zwi,et al.  Factors influencing resource allocation decisions and equity in the health system of Ghana. , 2009, Public health.

[20]  Hugh P Possingham,et al.  Setting Conservation Priorities , 2009, Annals of the New York Academy of Sciences.

[21]  A. Ghaffar.  Setting research priorities by applying the combined approach matrix. , 2009, The Indian journal of medical research.

[22]  M. Krahn,et al.  Health technology assessment: A comprehensive framework for evidence-based recommendations in Ontario , 2009, International Journal of Technology Assessment in Health Care.

[23]  M. Kamlet,et al.  QALYs: some challenges. , 2009, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[24]  Sarah Bowen,et al.  More than "using research": the real challenges in promoting evidence-informed decision-making. , 2009, Healthcare policy = Politiques de sante.

[25]  Douglas K. Martin,et al.  Fairness and accountability for reasonableness. Do the views of priority setting decision makers differ across health systems and levels of decision making? , 2009, Social science & medicine.

[26]  E. Emanuel,et al.  Principles for allocation of scarce medical interventions , 2009, The Lancet.

[27]  N. Hawkes.  NICE goes global , 2009, BMJ : British Medical Journal.

[28]  L. Erickson,et al.  Evidence and Value: Impact on DEcisionMaking – the EVIDEM framework and potential applications , 2008, BMC health services research.

[29]  Andrew Tannahill,et al.  Beyond evidence--to ethics: a decision-making framework for health promotion, public health and health improvement. , 2008, Health promotion international.

[30]  Charles Acquah,et al.  Balancing equity and efficiency in health priorities in Ghana: the use of multicriteria decision analysis. , 2008, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[31]  Alasdair Breckenridge,et al.  Balancing early market access to new drugs with the need for benefit/risk data: a mounting dilemma , 2008, Nature Reviews Drug Discovery.

[32]  Kristian Lampe,et al.  Ethical analysis to improve decision-making on health technologies. , 2008, Bulletin of the World Health Organization.

[33]  Ari Natter,et al.  To fund or not to fund , 2008 .

[34]  S. Gruskin,et al.  Justice and Human Rights: Priority Setting and Fair Deliberative Process , 2008 .

[35]  M. Schlander,et al.  The use of cost-effectiveness by the National Institute for Health and Clinical Excellence (NICE): no(t yet an) exemplar of a deliberative process , 2008, Journal of Medical Ethics.

[36]  S. Quartz,et al.  The Right and the Good: Distributive Justice and Neural Encoding of Equity and Efficiency , 2008, Science.

[37]  Hanna Toiviainen,et al.  Decision-making in priority setting for medicines--a review of empirical studies. , 2008, Health policy.

[38]  S Bryan,et al.  The use of economic evaluations in NHS decision-making: a review and empirical investigation. , 2008, Health technology assessment.

[39]  M. Giacomini.  How good is good enough? Standards in policy decisions to cover new health technologies. , 2007, Healthcare policy = Politiques de sante.

[40]  Becky Skidmore,et al.  Priority setting for health technology assessments: A systematic review of current practical approaches , 2007, International Journal of Technology Assessment in Health Care.

[41]  R. Baltussen,et al.  Priority setting using multiple criteria: should a lung health programme be implemented in Nepal? , 2007, Health policy and planning.

[42]  Richard Fordham,et al.  Prioritizing health technologies in a Primary Care Trust , 2007, Journal of health services research & policy.

[43]  Douglas K. Martin,et al.  Priority setting and cardiac surgery: a qualitative case study. , 2007, Health policy.

[44]  Bryn Williams-Jones,et al.  Mapping the integration of social and ethical issues in health technology assessment , 2007, International Journal of Technology Assessment in Health Care.

[45]  R. Baltussen,et al.  Priority setting of health interventions: the need for multi-criteria decision analysis , 2006, Cost effectiveness and resource allocation : C/E.

[46]  C. Mitton,et al.  Priority setting in the Provincial Health Services Authority: case study for the 2005/06 planning cycle. , 2006, Healthcare policy = Politiques de sante.

[47]  Elly Stolk,et al.  Towards a multi-criteria approach for priority setting: an application to Ghana. , 2006, Health economics.

[48]  R. Fordham,et al.  Developing a prioritisation framework in an English Primary Care Trust , 2006, Cost effectiveness and resource allocation : C/E.

[49]  Douglas K. Martin,et al.  Ethics and economics: does programme budgeting and marginal analysis contribute to fair priority setting? , 2006, Journal of health services research & policy.

[50]  N. Barber,et al.  Reimbursement decisions in health policy--extending our understanding of the elements of decision-making. , 2005, Health policy.

[51]  B. Hofmann.  Toward a procedure for integrating moral issues in health technology assessment , 2005, International Journal of Technology Assessment in Health Care.

[52]  A. Zwi,et al.  Pathways to “Evidence-Informed” Policy and Practice: A Framework for Action , 2005, PLoS medicine.

[53]  Douglas K. Martin,et al.  Evidence, economics and ethics: resource allocation in health services organizations. , 2005, Healthcare quarterly.

[54]  P. Mullen,et al.  Quantifying priorities in healthcare: transparency or illusion? , 2004, Health services management research.

[55]  P. Braveman,et al.  Defining equity in health , 2003, Journal of epidemiology and community health.

[56]  Douglas K. Martin,et al.  Priority-setting decisions for new cancer drugs: a qualitative case study , 2001, The Lancet.

[57]  Norman Daniels,et al.  Justice, Health, and Healthcare , 2001, The American journal of bioethics : AJOB.

[58]  Norman Daniels,et al.  Decisions about access to health care and accountability for reasonableness , 1999, Journal of Urban Health.

[59]  N. Daniels,et al.  Limits to health care: fair procedures, democratic deliberation, and the legitimacy problem for insurers. , 1997, Philosophy & public affairs.

[60]  Johan L. Severens,et al.  Economic evaluations of healthcare programmes and decision making , 2012, PharmacoEconomics.

[61]  J. Dolan.  Multi-criteria clinical decision support: A primer on the use of multiple criteria decision making methods to promote evidence-based, patient-centered healthcare , 2011 .

[62]  Arielle Lasry,et al.  Allocating funds for HIV/AIDS: a descriptive study of KwaDukuza, South Africa. , 2011, Health policy and planning.

[63]  Jacques LeLorier,et al.  Evidence and values: requirements for public reimbursement of drugs for rare diseases--a case study in oncology. , 2009, The Canadian journal of clinical pharmacology = Journal canadien de pharmacologie clinique.

[64]  B. Manns,et al.  6-STEPPPs: A Modular Tool to Facilitate Clinician Participation in Fair Decisions for Funding New Cancer Drugs. , 2008, Journal of oncology practice.

[65]  E. Somers,et al.  The public funding of expensive cancer therapies: synthesizing the "3Es"--evidence, economics, and ethics. , 2008, Organizational ethics : healthcare, business, and policy : OE.

[66]  L. Ericksona,et al.  An analytical framework for immunization programs in Canada , 2005 .

[67]  P. Trueman,et al.  Research into the use of health economics in decision making in the United Kingdom--Phase II. Is health economics 'for good or evil'? , 1999, Health policy.

[68]  J. Dettori,et al.  Health technology assessment , 2009, International Journal of Technology Assessment in Health Care.